We are live on ! Find out more
TG

TLP Group Portfolio holdings

AUM $6.61M
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+18.07%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$14.9M
Cap. Flow
-$292K
Cap. Flow %
-0.2%
Top 10 Hldgs %
64.22%
Holding
794
New
229
Increased
159
Reduced
207
Closed
182

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$3.53M
2
PFE icon
Pfizer
PFE
+$2.63M
3
MRK icon
Merck
MRK
+$1.44M
4
AMGN icon
Amgen
AMGN
+$1.26M
5
LLY icon
Eli Lilly
LLY
+$976K

Top Sells

Rank Stock Value
1
AIMT
Aimmune Therapeutics
AIMT
+$30.2M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.96M
3
GM icon
General Motors
GM
+$484K
4
DSKEW
Daseke, Inc. Warrant
DSKEW
+$417K
5
TSLA icon
Tesla
TSLA
+$395K

Sector Composition

Rank Sector Weight
1 Healthcare 8.73%
2 Financials 6.69%
3 Consumer Discretionary 5.75%
4 Industrials 4.37%
5 Technology 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDNS icon
301
Cadence Design Systems
CDNS
$91.1B
$16K 0.01%
383
+345
+908% +$14.8K
MMM icon
302
3M
MMM
$87.5B
$16K 0.01%
81
-1,486
-95% -$286K
SIRI icon
303
SiriusXM
SIRI
$10.1B
$16K 0.01%
300
-72
-19% -$3.98K
TYL icon
304
Tyler Technologies
TYL
$11.9B
$16K 0.01%
+93
New +$16.5K
XOM icon
305
ExxonMobil
XOM
$650B
$16K 0.01%
188
+62
+49% +$5.13K
TUP
306
DELISTED
Tupperware Brands Corporation
TUP
$16K 0.01%
+256
New +$15.7K
ABMD
307
DELISTED
Abiomed Inc
ABMD
$16K 0.01%
+84
New +$15.7K
HRC
308
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$16K 0.01%
193
-3,660
-95% -$296K
APC
309
DELISTED
Anadarko Petroleum
APC
$16K 0.01%
+304
New +$14.9K
AGO icon
310
Assured Guaranty
AGO
$3.73B
$15K 0.01%
434
+87
+25% +$3.15K
AZO icon
311
AutoZone
AZO
$47.7B
$15K 0.01%
21
+20
+2,000% +$12.8K
CBOE icon
312
Cboe Global Markets
CBOE
$29.8B
$15K 0.01%
124
+70
+130% +$8.2K
CMCSA icon
313
Comcast
CMCSA
$78.3B
$15K 0.01%
+377
New +$14.2K
EXPD icon
314
Expeditors International
EXPD
$23B
$15K 0.01%
+229
New +$14K
K
315
DELISTED
Kellanova
K
$15K 0.01%
+235
New +$14.1K
LAMR icon
316
Lamar Advertising Co
LAMR
$16B
$15K 0.01%
+202
New +$14.7K
MPT
317
Medical Properties Trust
MPT
$2.87B
$15K 0.01%
1,119
+37
+3% +$500
OSK icon
318
Oshkosh
OSK
$9.48B
$15K 0.01%
+162
New +$14.2K
PII icon
319
Polaris
PII
$4.13B
$15K 0.01%
119
-117
-50% -$13.9K
RS icon
320
Reliance Steel & Aluminium
RS
$20.2B
$15K 0.01%
175
-3,428
-95% -$270K
SYK icon
321
Stryker
SYK
$122B
$15K 0.01%
96
+26
+37% +$3.97K
USFD icon
322
US Foods
USFD
$21B
$15K 0.01%
468
-9,826
-95% -$278K
WPC icon
323
W.P. Carey
WPC
$16.7B
$15K 0.01%
224
-3,524
-94% -$241K
CAH icon
324
Cardinal Health
CAH
$52.9B
$14K 0.01%
226
-3,981
-95% -$246K
CME icon
325
CME Group
CME
$91.9B
$14K 0.01%
93
+59
+174% +$8.4K
11 12
13
14 15

Similar funds

LAM
Lyxor Asset Management New York $8.58M AUM 3.07% 1-Year Est. Return
SPCP
Snow Park Capital Partners New York $3.17M AUM 3.35% 1-Year Est. Return
GZ
George Zachary $2.34M AUM 5.28% 1-Year Est. Return
RGNCM
R.G. Niederhoffer Capital Management New York $11.3M AUM
FCM
Force Capital Management New York $11.4M AUM 5.65% 1-Year Est. Return
DCM
Dynamic Capital Management St. Helier, Jersey $12M AUM 0.65% 1-Year Est. Return
DAL
David A. Lorber $1.11M AUM 4.74% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

TLP Group's Q4 2017 Portfolio in Review

As of Q4 2017, TLP Group held 794 positions worth $144M, down 9.4% from $159M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

TLP Group's Q4 2017 filing shows 229 new, 159 increased, 207 reduced and 182 closed positions. Its largest new stake was iShares Biotechnology ETF: 4,800 shares worth $512K. The largest sale was Aimmune Therapeutics, an estimated $30.2M.

By sector, the portfolio is most concentrated in Healthcare at 8.7% of assets, up from 4.8% a quarter earlier, followed by Financials and Consumer Discretionary.

  • TLP Group's largest Q4 2017 buy was iShares Biotechnology ETF: 4,800 shares worth $512K.
  • TLP Group added most to iShares Russell 2000 ETF in Q4 2017, an estimated $3.53M increase.
  • TLP Group's biggest Q4 2017 reduction was Aimmune Therapeutics, cutting an estimated $30.2M.
  • TLP Group fully exited Daseke, Inc. Warrant in Q4 2017, selling an estimated $417K.
  • TLP Group's ten largest holdings make up 64% of its $144M portfolio in Q4 2017.
  • TLP Group opened 229 new positions and closed 182 in Q4 2017.
  • TLP Group's portfolio value fell 9.4% quarter-over-quarter to $144M.

Based on TLP Group's 13F filing for Q4 2017, filed 14 Feb 2018.